Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
An Acad Bras Cienc ; 94(2): e20210230, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35830083

RESUMEN

Wounds treated with TiO2 nanoparticles (TiO2-NPs) show an improvement in healing time. However, little is known about the parameters that can contribute to this result. On the other hand, the treatment of wounds with polyphenols is widely known. These compounds are found in the peel of Annona crassiflora fruit and have antioxidant, analgesic and anti-inflammatory properties. In this study, we evaluated the healing effect of TiO2 nanocrystals (TiO2-NCs), polyphenolic fractions obtained from ethanolic extract of A. crassiflora fruit peel (PFAC) and mix (PFAC + TiO2-NCs) on the parameters of wound closure, inflammation, collagen deposition, metalloproteinase activity (MMPs) and angiogenesis. TiO2-NCs and PFAC have activity for wound healing, showed anti-inflammatory action and a shorter wound closure time. These treatments also contributed to increased collagen deposition, while only treatment with TiO2-NCs increased MMP-2 activity, parameters essential for the migration of keratinocytes and for complete restoration of the injured tissue. The combination of PFAC + TiO2-NCs reduced the effectiveness of individual treatments by intensifying the inflammatory process, in addition to delaying wound closure. We conclude that the interaction between the hydroxyl groups of PFAC polyphenols with TiO2-NCs may have contributed to difference in the healing activity of skin wounds.


Asunto(s)
Annona , Nanopartículas , Annona/química , Antiinflamatorios/farmacología , Colágeno , Nanopartículas/química , Polifenoles/farmacología , Titanio , Cicatrización de Heridas
2.
An Acad Bras Cienc ; 92(1): e20181127, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32321021

RESUMEN

Obesity is characterized by the excess of body fat and, therefore, may cause musculoskeletal alterations that can negatively influence the tendons. Such overweight-influenced alterations are exercise sensitive though. Morphological and biochemical alterations were reported in the calcaneal tendon of mice submitted to a lipid-rich diets along with practicing exercises, with the following groups: normal diet without exercise (ND), normal diet with exercise (NDex), lipid-rich diet without exercise (LD), lipid-rich diet without exercise (LDex). The calcaneal tendons were removed and subjected to histological and biochemical analysis. Layers of the tissue were stained with Hematoxylin and Eosin, Picrosirius Red and Von Kossa while a protein dosage was conduce by the Bradford method. The morphologicals analysis there was no statistical difference concerning the number of fibroblasts among the groups. Groups submitted to exercises showed higher amount of collagen and non-collagenous protein deposition. The lipid-rich diet without exercse group had a more disorganized collagen matrix with intense basophilia. The same group had areas of calcification confirmed by Von Kossa technique. Practicing physical activity, such as swimming, can improve the changes caused in the calcaneal tendon in mice submitted to a lipid-rich diets, having a better collagen organization and the synthesis.


Asunto(s)
Tendón Calcáneo/metabolismo , Colágeno/metabolismo , Grasas de la Dieta/metabolismo , Lípidos/administración & dosificación , Metaloproteinasa 2 de la Matriz/metabolismo , Condicionamiento Físico Animal , Natación , Animales , Grasas de la Dieta/administración & dosificación , Masculino , Ratones
3.
J Exp Biol ; 217(Pt 18): 3274-82, 2014 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-25013116

RESUMEN

Traditionally, exercise physiology experiments have borne little resemblance to how animals express physical activity in the wild. In this experiment, 15 adult male rats were divided into three equal-sized groups: exercise contingent (CON), non-exercise contingent (NON) and sedentary (SED). The CON group was placed in a cage with a running wheel, where the acquisition of food was contingent upon the distance required to run. Every 3 days the distance required to run to maintain food intake at free feeding levels was increased by 90% in comparison to the previous 3 days. The NON group was housed identically to the CON group, but food acquisition was not dependent upon running in the wheel. Finally, the SED group was kept in small cages with no opportunity to perform exercise. A two-way ANOVA with repeated measures was used to determine significant differences in responses between the experimental phases and treatment groups, and ANCOVA was used to analyse growth and tissue mass variables with body length and body mass used separately as covariates. A post hoc Tukey's test was used to indicate significant differences. A Pearson's correlation was used to test the relationship between the distance travelled by the animal and the distance/food ratio. The level of significance was set at P<0.05 for all tests. The CON group showed the hypothesized correlation between distance required to run to obtain food and the mean distance travelled (P<0.001), during 45 days in the contingency phase. This group showed a decrease in body mass, rather than an increase as shown by NON and SED groups. The CON group had a significantly lower body temperature (P<0.05) and adiposity (P<0.05) when compared with the other two groups for the same body size. The present experimental model based on animals choosing the characteristics of their physical exercise to acquire food (i.e. distance travelled, speed and duration) clearly induced physiological effects (body characteristics and internal temperature), which are useful for investigating relevant topics in exercise physiology such as the link between exercise, food and body mass.


Asunto(s)
Ingestión de Alimentos/fisiología , Actividad Motora/fisiología , Esfuerzo Físico/fisiología , Carrera/fisiología , Animales , Temperatura Corporal , Masculino , Ratas , Ratas Wistar , Factores de Tiempo
4.
APMIS ; 121(5): 422-30, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23176365

RESUMEN

Statins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, have been shown to ameliorate a number of vascular diseases. We evaluated the inflammatory and angiogenic components of the fibrovascular tissue induced by subcutaneous implants in mice and their modulation by fluvastatin. Our results showed that the statin (0.6 and 6 mg/kg/day) inhibited hemoglobin (Hb) content (51%) and vascular endothelial growth factor (VEGF) levels (71%) in the treated group compared with the control group. The inflammatory component, as assessed by N-acetyl-ß-D-glucosaminidase activity and tumor necrosis factor-α (TNF-α) level was also decreased by the compound. In the treated group; the inhibition of the enzyme activity was 33% and the cytokine was 67% relative to the control. In these implants the statin was also able to decrease nitric oxide (NO) production, detected with an NO-sensitive electrode. To our knowledge this is the first study demonstrating an inhibitory role of fluvastatin on the production of NO in inflammatory angiogenesis of newly formed fibrovascular tissue.


Asunto(s)
Ácidos Grasos Monoinsaturados/farmacología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Indoles/farmacología , Inflamación/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Acetilglucosaminidasa/metabolismo , Animales , Quimiocina CCL2/metabolismo , Colesterol/sangre , Fluvastatina , Hemoglobinas/análisis , Inflamación/patología , Leucocitos/metabolismo , Lipasa/sangre , Masculino , Ratones , Neovascularización Patológica/patología , Óxido Nítrico/sangre , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo
5.
Clin Exp Pharmacol Physiol ; 38(4): 262-8, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21309808

RESUMEN

1. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA) inhibitors, exert anti-inflammatory, anti-oxidant and anti-angiogenic effects. These effects are associated with downregulation of pro-inflammatory/pro-angiogenic molecules and upregulation of endothelial nitric oxide synthase (e-NOS) expression/nitric oxide (NO) production. 2. Using the murine sponge model to induce chronic intraperitoneal inflammatory response, we evaluated the inflammatory components, angiogenic and NO production of the fibrovascular tissue, and their modulation by fluvastatin. 3. Our results showed that fluvastatin (0.6 and 6 mg/kg per day) inhibited haemoglobin (Hb) content 4.9±0.4 (n=15; control) vs 2.2±0.2 (n=6; fluvastatin 0.6) and 1.8±0.2 (n=6; fluvastatin 6.0) and the number of vessels in the treated group when compared with the control group. The inflammatory component, as assessed by myeloperoxidase and N-acetyl-ß-d-glucosaminidase activities and by the pro-inflammatory cytokines, tumour necrosis factor-α (TNF-α) and Monocyte chemotactic protein-1 (MCP-1)/CCL2/JE levels, was also decreased by the compound. In the treated group, inhibition of both enzyme activities was 54% and 57%, respectively. The levels of the cytokines (TNF-α and CCL2/JE) intra-implant were decreased relative to the control. In these implants, fluvastatin was also able to increase NO production, as detected with an NO-sensitive electrode. 4. The inhibitory function of fluvastatin on key components of intraperitoneal inflammatory angiogenesis shown in the present study is clearly associated with the modulatory effects of this statin on vascular endothelial growth factor, TNF-α and NO production.


Asunto(s)
Ácidos Grasos Monoinsaturados/farmacología , Indoles/farmacología , Neovascularización Patológica/tratamiento farmacológico , Peritonitis/tratamiento farmacológico , Acetilglucosaminidasa/metabolismo , Animales , Vasos Sanguíneos/efectos de los fármacos , Quimiocina CCL2/metabolismo , Fluvastatina , Hemoglobinas/antagonistas & inhibidores , Hemoglobinas/metabolismo , Implantes Experimentales , Masculino , Ratones , Neovascularización Patológica/metabolismo , Óxido Nítrico/biosíntesis , Peritoneo/irrigación sanguínea , Peritonitis/metabolismo , Peritonitis/patología , Peroxidasa/metabolismo , Poliuretanos/farmacología , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/biosíntesis
6.
Microvasc Res ; 78(3): 265-71, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19732781

RESUMEN

The specific PDE4 inhibitor (rolipram) has been shown to attenuate excessive accumulation/activation of inflammatory cells and fibroblasts and cytokine production in several pathological conditions through cyclic nucleotide modulation. Here, using the murine sponge model to induce chronic subcutaneous inflammatory response and to elicit the formation of intraperitoneal adhesions we explored the hypothesis that rolipram would exert beneficial effects on decreasing key components of both processes (inflammatory cell recruitment, angiogenesis, and deposition of extracellular matrix component). Two doses of rolipram (0.2 or 2 mg/kg/day) were administered orally for 7 days in groups of mice bearing either subcutaneous or intraperitoneal polyether-polyurethane implants. Rolipram was effective in inhibiting angiogenesis as assessed by hemoglobin content and VEGF levels in subcutaneous implants (about 40% with both doses) but failed to exert this activity in intraperitoneal implants. Conversely, accumulation of neutrophils and macrophages determined by measuring myeloperoxidase (MPO) and N-acetylglucosaminidase (NAG) activities intraimplant, respectively, was attenuated only in intraperitoneal implants by the treatment. Levels of TNF-alpha and MCP-1 were also determined and rolipram at both doses decreased the production of both cytokines in intraperitoneal implants. The levels of MCP-1 in the subcutaneous implants were not affected by the treatment. Fibrosis was evaluated by determining the amount of collagen and production of TGF-beta1 intraimplant. Both parameters were attenuated by rolipram. These results have shown differential sensitivity of proliferating tissues to PDE4 inhibitor indicating that this agent may be used to target inflammatory angiogenesis selectively.


Asunto(s)
Inflamación/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Peritoneo/efectos de los fármacos , Inhibidores de Fosfodiesterasa/farmacología , Rolipram/farmacología , Administración Oral , Animales , Quimiocina CCL2/metabolismo , Colágeno/metabolismo , Modelos Animales de Enfermedad , Fibrosis/tratamiento farmacológico , Fibrosis/metabolismo , Fibrosis/patología , Inflamación/metabolismo , Inflamación/patología , Macrófagos/efectos de los fármacos , Macrófagos/enzimología , Macrófagos/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Neutrófilos/patología , Peritoneo/metabolismo , Peritoneo/patología , Tapones Quirúrgicos de Gaza , Adherencias Tisulares/tratamiento farmacológico , Adherencias Tisulares/metabolismo , Adherencias Tisulares/patología , Factor de Crecimiento Transformador beta1/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...